MUMBAI The rupee rose to a two-week high on Friday, notching up a second consecutive week of gains, helped by inflows tied to a domestic share sale and by a weaker dollar after strong U.S. data raised chances of an early retreat from monetary easing.
The government was selling a 5 percent stake in state-run National Aluminium Co Ltd to raise at least 5.1 billion rupees.
The rupee also benefited as the dollar weakened globally after strong U.S. economic data raised the prospect the U.S. Federal Reserve may retreat earlier from its monetary easing programme.
Still, investors are widely looking ahead at the Reserve Bank of India's policy review on Tuesday amid expectations that the central bank will cut interest rates by 25 basis points in a bid to support economic growth.
"Corporate selling in the morning and gains in the euro have helped the rupee despite stocks turning negative," said Naveen Raghuvanshi, associate vice president at Development Credit Bank.
"If there is a rate cut on Tuesday, equities may gain and the rupee may rise to 53.70-53.75 levels."
The partially convertible rupee closed at 54.02/03 per dollar versus its previous close of 54.355/365. It rose to 53.97 in the session, the highest level since February 28.
The rupee gained 0.6 percent on the day, its biggest daily rise since January 30. For the week, it rose 0.5 percent.
Broader gains were capped after a Standard & Poor's analyst said the slowdown in India's growth was less supportive for the country's sovereign credit ratings.
S&P rated India at "BBB-minus", one notch above junk, and cut its outlook to "negative" from "stable" last year, denoting a one-in-three possibility of a ratings downgrade.
In the offshore non-deliverable forwards, the one-month contract was at 54.44, while the three-month was at 55.02.
In the currency futures market, the most-traded near-month dollar/rupee contracts on the National Stock Exchange, the MCX-SX and the United Stock Exchange all closed at around 54.19 with a total traded volume of $5.1 billion.
(Editing by Subhranshu Sahu)
Trending On Reuters
The double-digit stock market gains of pharmaceutical giants including Dr. Reddy's Laboratories and Wockhardt stand out in stark relief to the dismal performance of other Asian emerging-market stocks this year. Full Article